Sorrento Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Sorrento Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2023.
  • Sorrento Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 8, 2023 was 551M shares, a 22.5% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 551M +101M +22.5% Aug 8, 2023 10-Q 2023-08-14
Q1 2023 551M +162M +41.7% Mar 8, 2023 10-K 2023-03-16
Q3 2022 472M +166M +54% Nov 4, 2022 10-Q 2022-11-08
Q2 2022 450M +152M +50.9% Aug 8, 2022 10-Q 2022-08-15
Q1 2022 389M +102M +35.7% Apr 29, 2022 10-Q 2022-05-05
Q3 2021 306M +43.4M +16.5% Oct 23, 2021 10-Q 2021-11-05
Q2 2021 298M +56.1M +23.2% Jul 23, 2021 10-Q 2021-08-06
Q1 2021 287M +77M +36.7% Apr 30, 2021 10-Q 2021-05-05
Q4 2020 280M +99M +54.6% Feb 5, 2021 10-K 2021-02-19
Q3 2020 263M +121M +85.3% Oct 23, 2020 10-Q 2020-11-09
Q2 2020 242M +111M +84.8% Jul 31, 2020 10-Q 2020-08-04
Q1 2020 210M +87.1M +71.1% Apr 24, 2020 10-Q 2020-05-11
Q4 2019 181M Feb 14, 2020 10-K 2020-03-03
Q3 2019 142M +19.6M +16% Oct 22, 2019 10-Q 2019-11-12
Q2 2019 131M +14.2M +12.2% Jul 28, 2019 10-Q 2019-08-09
Q1 2019 123M +35.1M +40.2% Apr 26, 2019 10-Q 2019-05-15
Q3 2018 122M +43M +54.1% Nov 6, 2018 10-Q 2018-11-09
Q2 2018 117M +40.2M +52.5% Aug 6, 2018 10-Q 2018-08-09
Q1 2018 87.4M +36.5M +71.8% Mar 9, 2018 10-K 2018-03-16
Q3 2017 79.3M +21.4M +36.9% Nov 1, 2017 10-Q/A 2018-02-27
Q2 2017 76.5M +19M +33% Jul 27, 2017 10-Q 2017-08-09
Q1 2017 50.9M +12.5M +32.6% Mar 9, 2017 10-K/A 2017-03-27
Q3 2016 57.9M +20.2M +53.4% Nov 7, 2016 10-Q 2016-11-09
Q2 2016 57.6M +19.8M +52.5% Aug 2, 2016 10-Q 2016-08-08
Q1 2016 38.4M +2.16M +5.97% Mar 10, 2016 10-K 2016-03-15
Q3 2015 37.8M +8.83M +30.5% Nov 9, 2015 10-Q 2015-11-16
Q2 2015 37.8M +9.23M +32.3% Aug 3, 2015 10-Q 2015-08-07
Q1 2015 36.2M +13.2M +57.2% Mar 10, 2015 10-K 2015-03-16
Q3 2014 28.9M +7.25M +33.5% Oct 29, 2014 10-Q 2014-11-04
Q2 2014 28.5M +12M +72.9% Aug 1, 2014 10-Q 2014-08-06
Q1 2014 23M -313M -93.1% Mar 21, 2014 10-K 2014-04-01
Q3 2013 21.7M -278M -92.8% Nov 8, 2013 10-Q 2013-11-14
Q2 2013 16.5M -283M -94.5% Aug 12, 2013 10-Q 2013-08-13
Q1 2013 336M +73.7M +28.1% Mar 22, 2013 10-K/A 2013-03-27
Q3 2012 300M +50.2M +20.1% Oct 31, 2012 10-Q 2012-11-08
Q2 2012 300M +50.1M +20% Jul 31, 2012 10-Q 2012-08-14
Q1 2012 262M Mar 30, 2012 10-K 2012-03-30
Q3 2011 250M Oct 31, 2011 10-Q 2011-11-08
Q2 2011 250M Jul 31, 2011 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.